These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 35135218)

  • 1. Correction: New insights on novel coronavirus 2019-nCoV/SARS-CoV-2 modelling in the aspect of fractional derivatives and fixed points.
    Panda SK; Atangana A; Nieto JJ
    Math Biosci Eng; 2022 Jan; 19(2):1588-1590. PubMed ID: 35135218
    [No Abstract]   [Full Text] [Related]  

  • 2. New insights on novel coronavirus 2019-nCoV/SARS-CoV-2 modelling in the aspect of fractional derivatives and fixed points.
    Panda SK; Atangana A; Nieto JJ
    Math Biosci Eng; 2021 Oct; 18(6):8683-8726. PubMed ID: 34814319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying fixed point methods and fractional operators in the modelling of novel coronavirus 2019-nCoV/SARS-CoV-2.
    Panda SK
    Results Phys; 2020 Dec; 19():103433. PubMed ID: 33042771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV).
    Kumar S; Maurya VK; Prasad AK; Bhatt MLB; Saxena SK
    Virusdisease; 2020 Mar; 31(1):13-21. PubMed ID: 32206694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.
    Meo SA; Alhowikan AM; Al-Khlaiwi T; Meo IM; Halepoto DM; Iqbal M; Usmani AM; Hajjar W; Ahmed N
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2012-2019. PubMed ID: 32141570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses.
    Jaimes JA; André NM; Millet JK; Whittaker GR
    bioRxiv; 2020 Feb; ():. PubMed ID: 32511311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hybrid fractional optimal control for a novel Coronavirus (2019-nCov) mathematical model.
    Sweilam NH; Al-Mekhlafi SM; Baleanu D
    J Adv Res; 2021 Sep; 32():149-160. PubMed ID: 32864171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV).
    Dong S; Sun J; Mao Z; Wang L; Lu YL; Li J
    J Med Virol; 2020 Sep; 92(9):1542-1548. PubMed ID: 32181901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.
    Schwartz DA; Graham AL
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32050635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [2019-nCoV: new challenges from coronavirus].
    Tian HY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):235-238. PubMed ID: 32187929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein.
    Zhang H; Tu J; Cao C; Yang T; Gao L
    Biochem Biophys Res Commun; 2020 Aug; 529(2):251-256. PubMed ID: 32703419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge.
    Lupia T; Scabini S; Mornese Pinna S; Di Perri G; De Rosa FG; Corcione S
    J Glob Antimicrob Resist; 2020 Jun; 21():22-27. PubMed ID: 32156648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.
    Coutard B; Valle C; de Lamballerie X; Canard B; Seidah NG; Decroly E
    Antiviral Res; 2020 Apr; 176():104742. PubMed ID: 32057769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
    Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
    F1000Res; 2020; 9():576. PubMed ID: 32802318
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular docking analysis of N-substituted Oseltamivir derivatives with the SARS-CoV-2 main protease.
    Belhassan A; Chtita S; Zaki H; Lakhlifi T; Bouachrine M
    Bioinformation; 2020; 16(5):404-410. PubMed ID: 32831522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of 2019-Novel Coronavirus (2019-nCoV) by rRT-PCR at Mymensingh Medical College, Mymensingh, Bangladesh.
    Haque N; Bari MS; Ahmed S; Paul SK; Nasreen SA; Ahamed F; Islam A; Roy S; Abedin S; Khan MK; Fariha RH; Debnath P
    Mymensingh Med J; 2020 Jul; 29(3):589-595. PubMed ID: 32844798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer.
    Jeong S; Lee N; Lee SK; Cho EJ; Hyun J; Park MJ; Song W; Jung EJ; Woo H; Seo YB; Park JJ; Kim HS
    Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.
    Chan JF; Kok KH; Zhu Z; Chu H; To KK; Yuan S; Yuen KY
    Emerg Microbes Infect; 2020; 9(1):221-236. PubMed ID: 31987001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.